Animesh A. Sinha

Eng koʻp iqtibos qilingan asarlar

1. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan20224 iqtibos
2. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan20232 iqtibos
3. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan20241 iqtibos
4. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan20251 iqtibos
5. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-202020240 iqtibos
6. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis20250 iqtibos
7. Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan—A Retrospective Cohort Study20260 iqtibos

Hammualliflar

1. Norman Sitali6 ta umumiy asar2022–2026
2. S. Moe4 ta umumiy asar2023–2026
3. Sholpan Allamuratova4 ta umumiy asar2022–2025
4. Nargiza Parpieva4 ta umumiy asar2022–2025
5. Michael L. Rekart3 ta umumiy asar2024–2025
6. Khasan Safaev3 ta umumiy asar2024–2025
7. A. Khristusev3 ta umumiy asar2024–2025
8. Matthew J Saunders2 ta umumiy asar2025–2026
9. Zinaida Tigay2 ta umumiy asar2024–2025
10. Camilo Gomez Restrepo2 ta umumiy asar2024–2025

Barcha hammualliflar →